Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting
oleh: Xiaofu Zhu, Eitan Amir, Gurmit Singh, Mark Clemons, Christina Addison
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2014-03-01 |
Deskripsi
The annual Bone and The Oncologist New Updates (BONUS 8) conference focuses on the current understanding and dilemmas in the treatment and prevention of bone metastasis in cancer, as well as novel research on bone homeostasis and cancer-induced bone loss. We present commentaries from experts for their own take on where they feel the field of bone-targeted therapies for metastatic breast cancer is moving, or needs to move, if we are to make further progress.